DexCom (NASDAQ: DXCM) reported Q3 EPS of ($0.07), $0.06 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $105.2 million versus the consensus estimate of $99.88 million.

For earnings history and earnings-related data on DexCom (DXCM) click here.